hydrotalcite: Clinical Trials

6 trials of hydrotalcite, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 unknown. 4 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Unknown 1
Not applicable1Completed 1

Follow hydrotalcite: new trials by email Literature Review of hydrotalcite trials Research Report on hydrotalcite

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy
Hydrotalcite (Talcid, BAYX002833) - Gastroesophageal Reflux
RecruitingBayer1672025-11-182026-07-07
Therapeutic Effect of Isogladine Maleate on Small Intestinal Mucosal Injury Associated With NSAIDS in Population
Irsogladine Maleate, Hydrotalcite - NSAIDs-associated Intestinal Mucosal Injury
Phase 4UnknownLee's Pharmaceutical Limited1002022-04-012022-04-04
The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis
Talcid®, Chinese medicine prescription, Placebo - Chronic Atrophic Gastritis
Not applicableCompletedWangjing Hospital, China Academy of Chinese Medical Sciences4682018-03-122022-03-11
A Comparison of Effectiveness of Oral Sucrolfate, Alginate and Hydrotalcide in Dispeptic Pain Treatment
Alginate, Sucralfate, Hydrotalcite - Dyspepsia
Phase 4CompletedPamukkale University3002017-06-202018-08-31
A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic Pain
esomeprazole, Ranitidine, hydrotalcid - Dyspepsia
Phase 4CompletedPamukkale University2862013-03-012014-07-22
Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes
Talcid (Hydrotalcite, BAY4516H), Famotidine, Placebo - Heartburn
Phase 4CompletedBayer5592003-05-012014-12-25

Conditions studied

Dyspepsia (2)  ·  Heartburn (2)  ·  Emergencies (1)  ·  Gastritis, Atrophic (1)  ·  Gastroesophageal Reflux (1)  ·  Nausea (1)

Sponsors

Bayer (2)  ·  Pamukkale University (2)  ·  Lee's Pharmaceutical Limited (1)  ·  Wangjing Hospital, China Academy of Chinese Medical Sciences (1)

Countries

Germany (2)  ·  Turkey (Türkiye) (2)  ·  China (1)

Top investigators

Gulgun Battal, MD (1)  ·  Wei Wei, Ph.D (1)

Results publications

PMID 41932668